Navigation Links
US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
Date:2/28/2011

nd, effective April 11, 2011, an employer who fails to pay its employees required overtime compensation is subject to increased penalties.  "We are sure Novartis is aware of this development and will act accordingly to bring the Novartis overtime litigation to a just and expeditious resolution."

SWH serves as Lead or co-Lead Counsel for four new and nearly identical wage and hour class action suits now pending against other pharmaceutical companies by their U.S. sales representatives, including suits against Pfizer, Roche, Merck and Abbott Laboratories. SWH also recently secured the largest jury award in the U.S. in an employment discrimination case in May 2010 when a jury returned a verdict of $253 million in compensatory and punitive damage against Novartis Pharmaceuticals Corporation.  Novartis subsequently settled that case for $175 million.

About SWH

Sanford Wittels & Heisler LLP (SWH) is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in some of the major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters.


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Supreme Court of Israel Rules in Favor of Sun Pharma
2. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
3. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
6. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
7. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
8. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
9. Sensipar® Patents Upheld By District Court
10. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
11. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica US ... leading online community to help oncologists and other clinicians ... regarding the use of targeted therapies and immunotherapies, discusses ... and treatment.  Every September, Blood ... to raise awareness about blood cancers—helping to increase survival ...
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
(Date:9/19/2014)... and ORLANDO, Fla. , Sept. ... Inspire therapy continues to grow, with the publication of ... on-line in Otolaryngology – Head and Neck ... a worsening of both objective and subjective measures of ... attribute Inspire therapy for the reduction in obstructive sleep ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... SAN DIEGO, Sept. 15 Volcano Corporation (Nasdaq: ... $100 million aggregate principal amount of 2.875 percent convertible senior ... of 1933, as amended. Prior to June 1, 2015, the ... holders will receive up to the principal amount of the ...
... A new study conducted by Dobson | DaVanzo & ... durable medical equipment (DME) may limit Medicare beneficiaries, access ... the quality of products that Medicare consumers rely on. ... of millions of Americans who require oxygen equipment and ...
Cached Medicine Technology:Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015 2Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015 3Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015 4Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015 5Independent Study Concludes Medicare 'Competitive' Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities 2Independent Study Concludes Medicare 'Competitive' Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities 3Independent Study Concludes Medicare 'Competitive' Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities 4
(Date:9/19/2014)... (PRWEB) September 19, 2014 "I have ... getting wrinkles due to stretching the skin around my ... Ala. "This inspired me to design a more convenient ... CONTACT LENS SYSTEM provides a quicker, easier, more sanitary ... need to perform this task manually, saves time and ...
(Date:9/19/2014)... 2014 -- Recent two-generation approaches to reducing poverty ... increasing attention from researchers, advocates, and foundations. By ... them to move to jobs that offer a ... and education for children, these programs aim to ... according to a new report from the National ...
(Date:9/19/2014)... (HealthDay News) -- When it comes to firearm deaths, ... States, while the District of Columbia has the highest, ... deaths from gun-related violence -- including murders, suicides and ... the study revealed. Hawaii,s rate was roughly three per ... the District of Columbia had the highest rate of ...
(Date:9/19/2014)... Medical College of Wisconsin (MCW) scientists has identified a new ... mice and in humans. The findings are published in the ... Leah Solberg Woods, Ph.D., associate professor of pediatrics at MCW ... Institute, led the study and is the corresponding author of ... gene called Tpcn2 in which a variant was associated with ...
(Date:9/19/2014)... Top10BestSEOHosting.com today compares many professional Windows web hosting ... are the best suppliers of 2014. Clients who ... VPS and cloud hosting) at affordable rates can ... HostMonster ( http://www.hostmonster.com/track/seohosts ) helps business companies and ... the cost. As a top rated hosting provider, ...
Breaking Medicine News(10 mins):Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:Top10BestSEOHosting.com: They Are Best Windows Web Hosting Suppliers Of 2014 2
... use trends , , TUESDAY, March 4 (HealthDay News) -- When ... to give up the habit if it isn,t considered cool, ... research shows. , The findings will give prevention researchers ... embrace of illegal drugs, said study author Michelle Little, a ...
... to Take Action Against This Leading ... Cause of Home-Related Deaths, WASHINGTON, ... poisoning is the second leading,cause of home injury death in the ... one percent of U.S. adults ranked poisoning at the,top of the ...
... Estate Developer,s Foundation to Lead the ... in Ending Global Hunger, Improving Nutrition, NEW YORK, ... pledged a $15 million challenge grant to transform The ... Sciences in Rehovot, Israel. The gift will be the ...
... received a five-year, $20.5 million grant from the Bill ... investigating the biological factors underlying immune system control of ... provides support to the International HIV Controllers Study, which ... and has the overall goal of discovering information that ...
... Award and Massachusetts again takes ... top e-Prescribing State Honors, ... the leader in hosted services for email encryption and,e-prescribing, today ... 2008, for building awareness of improving,patient safety at the local ...
... AUSTIN, TX and TORONTO, March 4 /PRNewswire/ - ... dosing of healthy subjects in,a Phase I study ... from its,novel class of fatty acid biosyntheis inhibitors. ... and pharmacokinetics of a single,escalating oral dose. Affinium ...
Cached Medicine News:Health News:Troubled Boys Will Abandon Pot When It's Deemed Uncool 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 3Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 4Health News:Robert H. Smith 'Feeding the Future' with $15 Million Gift to Hebrew University of Jerusalem 2Health News:Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study 2Health News:Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study 3Health News:Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing 2Health News:Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing 3Health News:Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic 2